Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Fierce Pharma
Thu, 04/20/23 - 11:47 am
Tags:
Amgen
,
Otezla
,
immunology
,
generics
,
Sandoz
,
Zydus
,
patents
AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'
Fierce Biotech
Tue, 04/18/23 - 10:18 pm
Tags:
Eli Lilly
,
Amgen
,
Mirati Therapeutics
,
KRAS inhibitors
,
AACR
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
Tue, 04/11/23 - 07:18 pm
Tags:
layoffs
,
biotech
,
Amgen
,
Pfizer
,
Roche
,
Jounce Therapeutics
,
Fate Therapeutics
,
Molecular Templates
,
Sorrento Therapeutics
After 2022's M&A spree, Amgen CEO Bradway collects $21.4M payday
Fierce Pharma
Mon, 04/10/23 - 05:06 pm
Tags:
Amgen
,
Bob Bradway
,
Pharma CEOs
,
executive compensation
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Wed, 04/5/23 - 07:15 pm
Tags:
Amgen
,
Prolia
,
Xgeva
,
denosumab
,
clinical trials
,
NIH
,
biosimilars
,
monoclonal antibodies
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
BioPharma Dive
Wed, 03/29/23 - 03:56 pm
Tags:
Amgen
,
JNJ
,
Stelara
,
psoriasis
,
patents
,
biosimilars
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
Fierce Pharma
Wed, 03/29/23 - 09:58 am
Tags:
AstraZeneca
,
Amgen
,
Tezspire
,
UK
,
NICE
,
asthma
,
severe asthma
Amgen cites inflation, pressure on drug prices in 450-person layoff
Endpoints
Fri, 03/17/23 - 09:59 am
Tags:
Amgen
,
California
,
layoffs
Amgen is sued for concealing $10.7 billion tax bill from investors
Reuters
Wed, 03/15/23 - 11:11 am
Tags:
Amgen
,
taxes
,
legal
,
Puerto Rico
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Fierce Biotech
Tue, 03/7/23 - 11:45 am
Tags:
Volastra Therapeutics
,
Eli Lilly
,
funding
,
sovilnesib
,
Amgen
,
cancer
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
Fri, 03/3/23 - 11:56 am
Tags:
JNJ
,
patents
,
Janssen
,
Amgen
,
biosimilars
,
Stelara
Could This Humira Biosimilar Be a Winner for Amgen?
Motley Fool
Fri, 03/3/23 - 11:48 am
Tags:
Amgen
,
biosimilars
,
Amjevita
,
Humira
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Fierce Biotech
Tue, 02/28/23 - 10:03 am
Tags:
Junshi Biosciences
,
Amgen
,
Sanofi
,
China
,
clinical trials
,
PCSK9 inhibitors
Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US
Pharmaceutical Business Review
Fri, 02/17/23 - 09:44 am
Tags:
Fresenius Kabi
,
Stimufend
,
pegfilgrastim
,
biosimilars
,
Neulasta
,
Amgen
,
cancer
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
Thu, 02/16/23 - 04:49 pm
Tags:
biosimilars
,
PBMs
,
physicians
,
AbbVie
,
Humira
,
Amgen
,
Amjevita
Amgen bond offering to help fund Horizon Therapeutics acquisition
Seeking Alpha
Thu, 02/16/23 - 11:25 am
Tags:
Amgen
,
bond
,
M&A
,
Horizon Therapeutics
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
Tags:
layoffs
,
Grifols
,
Frequency Therapeutics
,
Eliem Therapeutics
,
Aligos Therapeutics
,
Thermo Fisher Scientific
,
Magenta Therapeutics
,
Eisai
,
Amgen
,
Y-mAbs Therapeutics
,
Century Therapeutics
,
Elevation Oncology
,
Calithera Biosciences
,
Editas Medicine
,
Verily
,
Abzena
Layoffs continue to batter biotech, with Big Pharmas piling on the pain
Fierce Biotech
Wed, 02/1/23 - 10:32 pm
Tags:
layoffs
,
Amgen
,
Merck KGaA
,
TCR2 Therapeutics
,
Moderna Therapeutics
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Forbes
Wed, 02/1/23 - 10:41 am
Tags:
Amgen
,
Amjevita
,
AbbVie
,
Humira
,
biosimilars
,
drug pricing
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.